Liver Biology, Diseases & Cancer

Suzhou, China
December 4-8, 2017
Abstract deadline: October 23, 2017

Organized by:

Gen-Sheng Feng, University of California, San Diego, USA

Lijian Hui, Shanghai Institute for Biological Sciences, CAS, China

Atsushi Miyajima, The University of Tokyo, Japan

Lars Zender, University Hospital Tuebingen, Germany 

We are pleased to announce the 4th Cold Spring Harbor Asia conference on Liver Biology, Disease & Cancer which will be held in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday December 4, and will conclude after lunch on December 8, 2017.

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in basic, translational & clinical liver research. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

Major Topics:
1. Liver Progenitor Cells and iPS Cells
2. Hepatic Cell Fate Determination and Lineage Tracing
3. Liver Injuries, Repair and Treatment
4. Alcoholic and Non-Alcoholic Steatohepatitis
5. Hepatic Fibrogenesis and Therapeutics
6. Hepatocarcinogenesis and Novel Therapy
7. Immunotherapy for Liver Cancer

Keynote Speakers:
Lieping Chen, Yale University School of Medicine, USA
Inder Verma, The Salk Institute, USA
Abstract title: Cancer Stem Cells: Learning from Gliomas

Invited Speakers:
Fan Bai, Peking university, China
Abstract title: Intra-tumor genomic heterogeneity of Hepatocellular Carcinoma and combined Hepatocellular and Intrahepatic Cholangiocarcinoma
Rene Bernards, Netherlands Cancer Institute, THE NETHERLANDS
Abstract title: Finding new vulnerabilities of cancer cells for therapeutic benefit.
David Brenner, University of California, San Diego, USA
Abstract title: NADPH oxidase 1 promotes the development of hepatocellular carcinoma.
Xin Chen, University of California, San Francisco, USA
Abstract title: Combined CDK4/6 inhibitor and mTOR inhibitor for the treatment of cholangiocarcinoma
Gen-Sheng Feng, University of California, San Diego, USA
Abstract title: A New Preventive Therapy for Liver Cancer by Systematic Modulation of Innate and Adaptive Immunity
Ping Gao, University of Science & Technology of China, CHINA
Abstract title: Menin enhances c-Myc-mediated transcription to promote cancer progression
Markus Grompe, Oregon Health and Sciences University, USA
Abstract title: Injury responses in the liver
Tim Greten, National Cancer Institute, USA
Abstract title: The "immune" environment of HCC
Xin-Yuan Guan, The University of Hong Kong, CHINA
Abstract title: PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration activity and reprogramming glucose metabolism
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Abstract title: Involvement of the immune system in NASH and NASH-to-HCC transition
Lijian Hui, Shanghai Institute for Biological Sciences, CHINA
Abstract title: Cell identity conversion under epigenetic regulation
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Abstract title: Programmed Cell Death in Inflammation and Liver Cancer
Atsushi Miyajima, University of Tokyo, JAPAN
Abstract title: Roles of hepatic non-parenchymal cells for liver fibrosis
David Moore, Baylor College of Medicine, USA
Abstract title: Regulation of liver energy balance by nutrient-sensing nuclear receptors
Takahiro Ochiya, National Cancer Center Research Institute, JAPAN
Abstract title: Conversion of mature hepatocytes into liver progenitor cells
Eli Pikarsky, The Hebrew University of Jerusalem, ISRAEL
Abstract title: Focal liver inflammation and HCC
Shuji Terai, Niigata University, JAPAN
Abstract title: Stem Cell therapy for liver cirrhosis -From autologous cell to allogeneic cell-
Fu-sheng Wang, Beijing 302 Hospital, CHINA
Xin Wei Wang, National Institute of Health, USA
Abstract title: Biological and clinical impacts of intertumor and intratumor heterogeneity in liver cancer
Yunfang Wang, Beijing Institute of Transfusion Medicine, CHINA
Abstract title: In vitro liver models for drug hepatotoxicity eva1uation
Wei-Fen Xie, Changzheng Hospital, Second Military Medical University, CHINA
Abstract title: Chronic liver injuries induce the reprogramming of CK19+ biliary epithelial cells to hepatocytes
Shiou-Hwei Yeh, National Taiwan University College of Medicine, TAIWAN
Abstract title: Metabolism and Gender: Hepatic Androgen Receptor in NAFLD Pathogenesis
Victor Yu, National University of Singapore, SINGAPORE
Abstract title: MOAP-1 and Bid co-operate to execute Fas-mediated hepatocellular apoptosis but act paradoxically in regulating tumorigenesis in liver
Lars Zender, University Hospital Tuebingen, GERMANY
Abstract title: Functional Genetic Screening and Academic Drug Discovery to Improve Treatment of Patients with Liver Disease
Bin Zhou, Shanghai Institutes for Biological Sciences, CAS, CHINA
Abstract title: Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration
Jian Zhou, Zhongshan Hospital, Fudan Unviersity, CHINA
Abstract title: Liver Cancer: Diagnosis and Treatment in China
Jessica Zucman-Rossi, INSERM U674, FRANCE

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers. 


Fellowship: 
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit Stipends

We look forward to seeing you at Suzhou in December, 2017.

Sponsored by:

Package Content:

Please kindly note:

1. Registration includes food, but does NOT include Housing. Due to requests from participants to provide more housing at lower prices, we have expanded our housing options to include some lower priced nearby hotels. After completing the online registration, you will receive a link to the full list of housing options.
*Reference Room Rate:
CNY 500 per standard room per night in the Conference Hotel (Worldhotel Grand Dushulake Suzhou)
Up from CNY 200 per standard room per night in nearby budget hotels (within 5 km)
CNY 400-700 per standard room per night in nearby 4-5 star hotels

2. The meeting registration is an integral package. We encourage all our participants to stay for the full meeting period and communicate with each other. No refund/discount or day pass is available for partial participation.

3. The early price will be available if the full payment is finished before the exact due date.
For USD participants, we will automatically change your package price to the update one if we could not successfully charge the payment from your registered credit card before the deadline.
For CNY participants, we will automatically change your package price to the update one if our bank account could not receive your full payment by wire transfer before the deadline.

4. For late registrations, your registration materials may not be guaranteed since the order is usually made in advance.

5. Please inform us your special request on food (vegetarian, kosher…etc.) or other things during the online registration or email us as early as possible so that we could make relevant arrangement accordingly.

6. Student package is exclusively designed for all the graduate, undergraduate and doctor students who have not received the doctor degree. (Student ID will be required upon arrival).

Currency converter